American Head

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

Retrieved on: 
Wednesday, April 17, 2024
Public, CPD, Real, Nephrology, Ophthalmology, AIDX, National Kidney Foundation, AI, Research, Health, AMIA, TSX, American Head, Conference, Artificial intelligence, Chronic kidney disease, Guideline, QC, Health information management, Oropharyngeal cancer, Patient, Faculty, Otorhinolaryngology, American Medical Informatics Association, NKF, Entertainment center, Knowledge

Pentavere will be presenting at the following medical conferences:

Key Points: 
  • Pentavere will be presenting at the following medical conferences:
    Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC.
  • American Medical Informatics Association (AMIA) Clinical Informatics Conference on May 21-23, 2024 in Minneapolis, MN.
  • Presenting Research: Using Artificial Intelligence to automate the extraction of staging criteria from the electronic health records of oropharyngeal cancer patients.
  • Thought leaders driving the future of healthcare delivery will explore practice-ready solutions to enhance patient experiences, reduce costs, and improve public health.

Jaime Aldama Named as New President of Momentus Securities

Retrieved on: 
Tuesday, April 16, 2024
Small Business, Banking, Professional Services, Finance, Ecosystem, Capital market, Société Générale, Security (finance), American Head, Lehman Brothers, Multimedia, Citigroup, FINRA, University College Dublin, Organization

Momentus Securities — a registered broker-dealer and FINRA member — is proud to announce that Jaime Aldama has been named the new President of Momentus Securities, effective April 1, 2024.

Key Points: 
  • Momentus Securities — a registered broker-dealer and FINRA member — is proud to announce that Jaime Aldama has been named the new President of Momentus Securities, effective April 1, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240415014533/en/
    Jaime Aldama, President of Momentus Securities (Photo: Business Wire)
    Mr. Aldama was one of Momentus Securities’ first employees, joining in July 2022 as its Head of Capital Markets.
  • His contributions were integral in preparing Momentus Securities for its official launch in 2023, and he has continued to guide Momentus Securities as it seeks to fulfill its mission as an investment bank with a social purpose.
  • Momentus Securities is part of the Momentus Capital branded family of organizations , which is committed to building inclusive and equitable communities.

Over 20 Presentations on Alluminox Treatment (Photoimmunotherapy) at International Conferences in 2023

Retrieved on: 
Friday, March 1, 2024
Head, SAN, American Head, Sakigake, Neoplasm, ASCO, SITC, Hope, Rakuten, Society, Safety, Biomarker, Health, Clinical trial, Immunotherapy, Abstract, Dentistry

Mickey Mikitani, Co-CEO of Rakuten Medical, said, "Witnessing the surge in findings on Alluminox treatment shared at prestigious conferences around the world fills me with immense pride.

Key Points: 
  • Mickey Mikitani, Co-CEO of Rakuten Medical, said, "Witnessing the surge in findings on Alluminox treatment shared at prestigious conferences around the world fills me with immense pride.
  • We would like to thank all the dedicated healthcare professionals worldwide who share their excitement for this innovative technology and the potential of the Alluminox™ platform.
  • Together with the medical community, we remain committed to advancing this treatment and shaping the future of patient care."
  • With the increase in the number of treatment cases in the clinic, a range of findings on the Alluminox treatment have been reported, including treatment results and management of adverse events.

HEALWELL AI’s Pentavere Referenced by Several Leading Global Organizations for its Strength in Artificial Intelligence for Preventative Care

Retrieved on: 
Thursday, February 8, 2024
Consensus, Partnership, AACR, EMR, AIDX, Knowledge, Health information management, AI, NSCLC, Research, Breast cancer, OECD, Patient, Diagnosis, American Head, Data science, TSX, Entrepreneurship, Oropharyngeal cancer, Lung cancer, Artificial intelligence, Health, Medicine, Organization, Conference, Medical device

Pentavere continues to publish ground-breaking AI work accepted at prestigious global medical conferences and leading oncology organizations.

Key Points: 
  • Pentavere continues to publish ground-breaking AI work accepted at prestigious global medical conferences and leading oncology organizations.
  • In the past quarter Pentavere presented its AI work, in partnership with leading academic centers and global pharmaceutical companies at a number of prestigious conferences.
  • TORONTO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce that its subsidiary Pentavere Research Group Inc. (“Pentavere”), continues to publish ground-breaking AI work accepted at prestigious global medical conferences and leading oncology organizations.
  • Using Artificial Intelligence to automate the extraction of staging criteria from the electronic health records of oropharyngeal cancer patient.

Quantexa Partners with the Anti-Human Trafficking Intelligence Initiative (ATII) to Intensify the Fight Against Human Trafficking

Retrieved on: 
Thursday, January 11, 2024
Partnership, AI, ESG, ATII, Child, Finance, Organization, AML, International Labour Organization, ID, Advisory Council, American Head, Drug

The International Labor Organization estimates that 50 million1 people are victims of human trafficking globally, with human trafficking operating as a $150 billion2 industry around the world.

Key Points: 
  • The International Labor Organization estimates that 50 million1 people are victims of human trafficking globally, with human trafficking operating as a $150 billion2 industry around the world.
  • Together, Quantexa and ATII will make pioneering global human trafficking risk data available to more organizations to transform anti-human trafficking efforts and joint initiatives between the private and public sectors.
  • Providing access to a wider set of data points specific to human trafficking will enable investigators to take a more robust approach to anti-human trafficking measures.
  • “We’re proud to partner with the Anti-Human Trafficking Intelligence Initiative to support the valuable work that the organization is doing to stop human trafficking,” said Clark Frogley, North American Head of Financial Crime Solutions at Quantexa.

Rakuten Medical Presents AI-based Study in Two Posters on Immune Characteristics in Responders and Cellular Level Drug Quantification of Alluminox Treatment (Photoimmunotherapy) at SITC 2023

Retrieved on: 
Monday, November 6, 2023
Neoplasm, Data analysis, Biomarker, PD-1, Cell, American Head, SITC, Immunotherapy, Blood, Society, AI, Patient, Abstract, Pharmaceutical industry, Medical imaging

The posters present data that may be relevant to improved clinical outcomes with treatment based on Rakuten Medical's Alluminox™ platform (photoimmunotherapy).

Key Points: 
  • The posters present data that may be relevant to improved clinical outcomes with treatment based on Rakuten Medical's Alluminox™ platform (photoimmunotherapy).
  • Promising early evaluation data from the ASP-1929-181 study* was presented at the American Head and Neck Society (AHNS) in July 2023 (Abstract #: S252).
  • Rakuten Medical and Rakuten Institute of Technology Bengaluru have collaborated on AI-based analyses of patient samples since 2020.
  • The study results suggest that lower frequencies of CD8+ T cells in the blood at screening correlate with treatment response.

Yahoo Backstage Boosts CTV Capabilities with FreeWheel, Magnite’s SpringServe, and Publica by IAS Integrations

Retrieved on: 
Thursday, September 21, 2023
Online, Entertainment, Online Retail, Internet, Mobile Entertainment, Technology, Digital Marketing, Retail, Publishing, Marketing, Advertising, Communications, WPP plc, Freewheel, Yahoo! Sports, CTV, American Head, SPO, VEB Typoart, Fortune 500, Investment, Ecosystem, IAS, ROI, Yahoo! Finance, Internet service provider, Online shopping, Video game, Yahoo!, Magnite, Growth

The move allows connected TV (CTV) publishers to more seamlessly extend their premium inventory through Yahoo Backstage.

Key Points: 
  • The move allows connected TV (CTV) publishers to more seamlessly extend their premium inventory through Yahoo Backstage.
  • Among the 100, Yahoo Backstage includes nearly 40 CTV publishers, the largest representation of direct CTV supply available today.
  • Integrations with FreeWheel, Magnite’s streaming ad server, SpringServe, and Publica by IAS directly benefit CTV publishers by effortlessly extending their premium inventory through Yahoo Backstage.
  • The server-to-server connections between Yahoo Backstage and FreeWheel, Magnite, and Publica by IAS champion efficiency and transparency, promising a frictionless exchange of high-quality CTV inventory.

CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Results

Retrieved on: 
Friday, August 11, 2023
Research, Surgery, Clinical Trials, Biotechnology, Radiology, General Health, Pharmaceutical, Health, Science, Oncology, Condition, HPP, Neoplasm, Food, Policy, Survival, SCCHN, Head, American Head, PET-CT, Radiation therapy, Congress, NYSE, Patient, Physician, Data, NOCC, FDA, Health Canada, PD-L1, Pembrolizumab, Conference, Pharmaceutical industry, Medical imaging

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2023, as well as key clinical and corporate developments.

Key Points: 
  • CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2023, as well as key clinical and corporate developments.
  • Clinical and Corporate Developments this quarter include:
    CEL-SCI had a productive pre-submission meeting with Canada’s regulator, Health Canada, to determine the best regulatory path toward market approval.
  • CEL-SCI is preparing an application for the NOCC approval as suggested and plans to file it by early next year.
  • CEL-SCI reported a loss per share for the quarter ending June 30, 2023 of $0.19 versus a loss of $0.23 for the quarter of June 30, 2022.

EcoFlow and Winnebago Power Adventure and Off-Grid Living in New RV Option Featuring Built-in Energy Solution

Retrieved on: 
Thursday, July 20, 2023
Lighting, Partnership, Freedom, Life, Business, American Head, Snow, Kilowatt-hour, Freezing, Water, Air conditioning, Weather, Travel, Countertop, Internal, Solis, Video game, Tourism, Renewable energy, Electric battery, Electric motor, Propane, Transport, Hotel, Cargo, Cabinetry, RV

SEATTLE, July 20, 2023 /PRNewswire/ -- EcoFlow, a leading power management and eco-friendly energy solutions company, and Winnebago, the flagship brand of outdoor lifestyle product manufacturer Winnebago Industries, Inc., today announced the launch of the Solis Pocket 36B, featuring the exclusi­­ve Winnebago x EcoFlow Power Kit Pro.

Key Points: 
  • The optional Winnebago x EcoFlow Power Kit Pro developed in partnership with Winnebago features an exclusive 5-in-1 power management controller that consolidates five essential power components into one compact hub that optimizes energy performance.
  • "At EcoFlow, we want to make sustainable energy solutions that enable adventurous, off-grid living accessible and reliable to anyone, anywhere," said Brian Essenmacher, North American Head of Business Development at EcoFlow.
  • Combining a compact and powerful 5kWh house lithium battery with the Winnebago x EcoFlow Power Kit Pro, a 5-in-1 power management controller, Solis delivers best-in-class energy performance in a simple-to-use solution.
  • The 5-in-1 power management controller optimizes energy efficiency, simplifies vehicle operations and enhances the overall ownership experience by replacing five essential power components — inverter, shore power converter, battery energy converter, solar energy converter and alternator energy optimizer — into a single system.

CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer

Retrieved on: 
Tuesday, July 11, 2023
Research, FDA, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Oncology, Other Science, Programmed, Otorhinolaryngology, Therapy, Survival, Food and Drug Administration, SCCHN, Head, American Head, Neck, Doctor of Philosophy, TPS, Patient, Risk, PD-1, Recurrence, Pembrolizumab, PD-L1, NYSE, Conference, Food, Nivolumab, Pharmaceutical industry

These work by blocking the interaction between tumor cell PD-L1 and the PD-1 receptor.

Key Points: 
  • These work by blocking the interaction between tumor cell PD-L1 and the PD-1 receptor.
  • The global PD-L1/PD-1 therapeutics market was valued at $34.8 billion in 2022 and includes two drugs approved for head and neck cancer, specifically unresectable recurrent or metastatic SCCHN, Keytruda and Opdivo.
  • “Our immediate opportunity is in head and neck cancer, yet these latest results also point to potential in other solid tumors as well.
  • The Company is pursuing paths to marketing approval for Multikine in the treatment of head and neck cancer in the USA, Canada, the UK and the European Union.